Wu (2013) and coworkers proposed that, due to their steroid-based structure, F could interact with the androgen receptor (AR) and modulate the expression of target genes such as the prostate-specific antigen in prostate cancer cell lines. This evidence concerns the gene AR and prostate cancer.